AGAP14P

Across TCGA pan-cancer cohorts, AGAP14P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated AGAP14P data layer compared with 21 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher AGAP14P Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated AGAP14P expression acts as an unfavorable survival marker.

COAD, STAD, and SKCM are the cancer types where AGAP14P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.174	0.786	<.001	36	view →
STAD	OS	Median	II,III,IV	0.175	0.677	.002	24	view →
SKCM	DFS	Median	II,III,IV	0.015	0.709	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

AGAP14P–COAD (DFS)

Open the COAD breakdown →